bioMérieux S.A. (BMXMF)
Makes lab tests that identify bacterial infections and guide antibiotic treatment decisions.
$80.66+0.02%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-45.2%
The outlook
BMXMF is trading near the lower end of its 52-week range and sits below both its 50- and 200-day moving averages, signaling a downtrend. The stock carries a trailing P/E of 21.2, and analyst coverage appears limited. Current price momentum and technical positioning suggest a weak near-term setup.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range5% of the way from its 52-week low to high
Market cap
$9.51B
52-wk high
$152.00
52-wk low
$77.00
50-day avg
$81.35
200-day avg
$107.32
Trailing P/E
21.2